Dr Alleyn Plowright

VP, Head of Drug Discovery and Preclinical Development

Dr Alleyn Plowright is a VP, Head of Discovery and Preclinical Research at Pangea.

Alleyn is a seasoned drug discovery leader, with >20 years experience across a range of therapeutic areas, leading multi-disciplinary teams in AstraZeneca, Sanofi, and most recently as Head of Translational Science and Pre-clinical Development at Wren Therapeutics. He and his teams have contributed to the delivery of a range of compounds to the clinic, including two compounds currently in Phase 2 clinical trials.

Alleyn completed his PhD at the University of Nottingham, UK and postdoctoral studies at Harvard University. He has authored more than 70 publications and patents.

Inspired by nature.
Powered by technology.
Preserving knowledge.
Empowered by nature.
Empowered by nature.
Empowered by nature.
Empowered by nature.
Empowered by nature.